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Abstract 
Lipid accumulation in non adipose tissue is associated with various cases of tissue dysfunction and 
tissue failure. Reduced availability of oxygen is known to cause intracellular lipid accumulation in 
cardiomyocytes as well as in hearts. Cardiac lipid accumulation has been shown to cause impaired 
cardiac function but it is not fully clear how the lipids accumulate in the hypoxic myocardium. 
We have studied a model of hypoxic/ischemic myocardium using HL-1 cardiomyocytes incubated in 
hypoxic condition as well as an in vivo model where mice were subjected to a myocardial infarction 
causing cardiac ischemia. 
We found that the Very low density lipoprotein receptor (VLDLr), a member of the low density 
lipoprotein receptor (LDLr) family suggested to be able to mediate uptake of lipids, was significantly 
upregulated in response to hypoxia and that this upregulation was mediated through hypoxic activation 
of transcription factor Hif-1α. The VLDLr induced an increase in intracellular triglycerides which 
were mediated not primarily through increased uptake of fatty acids but from an increased uptake of 
extracellular triglyceride-rich lipoproteins. The uptake of lipoproteins was rapid in response to 
hypoxia. The increase in intracellular lipids caused an accumulation of cardiotoxic ceramides in the 
cardiomyocytes which induced myocardial ER-stress. ER-stress initially induces a cardioprotective 
response but prolonged ER-stress cause apoptosis which was increased when the VLDLr was 
expressed. Ablation of the VLDLr reduced the ER-stress. The mice lacking VLDLr expression 
showed a reduced infarct size which could be dependent on a reduced amount of toxic ceramides and 
apoptosis. 
We could also show that it was possible to block the harmful actions of the VLDLr by using VLDLr 
specific antibodies. Treatment with these antibodies reduced the lipid accumulation, ER-stress and 
apoptosis otherwise following a myocardial infarction. 
The hypoxic VLDLr expression is not restricted to species or tissue. We could see that the VLDLr was 
increased in human ischemic myocardium compared to non-ischemic biopsies. We could also see that 
the VLDLr expression was increased in human clear-cell renal carcinoma where in this case the 
increased VLDLr expression was not due to hypoxia but on constitutive Hif-1α activation. Like in the 
myocardium the VLDLr caused an accumulation of intracellular triglyceride in the cancer, which 
already contained great amounts of cholesterol esters. 
These results indicate that the VLDLr is an important mediator of post-ischemic intramyocardial lipid 
accumulation and that the blocking of this lipid uptake improves survival. 
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